Sabra Health Care REIT, Inc. (SBRA)
Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting Started
Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuation amid a strategic pivot to managed senior housing. SBRA reported Q2 2026 normalized AFFO of $0.40 per share, a ~5% YoY increase, with occupancy rising to 85.4% and guidance reaffirmed. Significant investments—$599 million YTD at ~7.5% yield—position SBRA for the Silver Tsunami, despite near-term macro and rate headwinds.
Sabra Health Care REIT: This 5.85% Healthcare REIT Is Undervalued
Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation and strong fundamentals. SBRA reported robust Q2 results: 24.7% revenue growth, 13.7% same-store managed senior housing NOI growth, and reaffirmed 2026 AFFO guidance. Recent acquisitions totaling $599 million at attractive yields, a healthy balance sheet, and ample liquidity support ongoing external growth.
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript
Sabra Healthcare REIT Q2 Earnings Call Highlights
Sabra Healthcare REIT NASDAQ: SBRA reported second-quarter 2026 normalized funds from operations of $0.38 per share and normalized adjusted funds from operations of $0.40 per share, with management reaffirming the higher full-year earnings outlook it issued in a July business update.
Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.4 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to FFO of $0.38 per share a year ago.
Strength Seen in Sabra (SBRA): Can Its 10.2% Jump Turn into More Strength?
Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in FFO estimate revisions might not help the stock continue moving higher in the near term.
Sabra Health Care: Pivoting To Win From An Unstoppable Demographic Tailwind
Sabra Health Care REIT remains a Buy, driven by its aggressive pivot into the Seniors Housing Operating Portfolio model. SBRA's SHOP transition offers direct exposure to demographic tailwinds from the 'Silver Tsunami,' positioning for significant potential occupancy and AFFO growth. Q1 results were strong, with AFFO at $0.39/share, nearly reaching the annual investment target, and a 77% dividend payout ratio supporting a ~6% yield.
SBRA vs. CUBE: Which Stock Is the Better Value Option?
Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Sabra Healthcare (SBRA) or CubeSmart (CUBE). But which of these two stocks offers value investors a better bang for their buck right now?
FVR vs. SBRA: Which Stock Is the Better Value Option?
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both FrontView REIT, Inc. (FVR) and Sabra Healthcare (SBRA). But which of these two stocks is more attractive to value investors?
Sabra Health Care REIT: A 6% Yield Backed By Powerful Demographic Tailwinds
Sabra Health Care REIT is a 'Buy' with a near 6% yield and 13x forward P/FFO, supported by favorable demographics and industry supply constraints. SBRA's Q1 2026 normalized FFO grew 9% YoY, driven by 14.4% same-store SHOP NOI growth and robust occupancy gains. Management is aggressively deploying capital into SHOP-focused acquisitions at 8% initial cash yields, with a strong pipeline and mostly fixed operating expenses enabling positive operating leverage.
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Sabra Healthcare (SBRA) Tops Q1 FFO and Revenue Estimates
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.39 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to FFO of $0.37 per share a year ago.
